UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission File Number: 001-42020
MAREX GROUP PLC
(Translation of registrant’s name into English)
155 Bishopsgate
London EC2M 3TQ
United Kingdom
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
Earnings Results
On May 16, 2024, Marex Group plc (the “Company”) issued a press release titled “Marex Group plc Full Year 2023 Results and Q1 2024 Update.” A copy of the press release is furnished as Exhibit 99.1 herewith.
UK Annual Report to Shareholders
On May 16, 2024, the Company published its UK Annual Report 2023 to Shareholders. The UK Annual Report 2023 to Shareholders is furnished as Exhibit 99.2 herewith.
EXHIBIT INDEX
The following exhibits are furnished as part of this Form 6-K:
Exhibit No. | Description | |
| 99.1 | Press release dated May 16, 2024 titled “Marex Group plc Full Year 2023 Results and Q1 2024 Update” | |
| 99.2 | UK Annual Report 2023 to Shareholders | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Marex Group plc | ||||||
| Date: May 16, 2024 | By: | /s/ Robert Irvin | ||||
| Robert Irvin | ||||||
| Chief Financial Officer | ||||||
